These findings collectively highlight the critical role of GPR120 in metabolic regulation, energy homeostasis, and endocrine signaling, further establishing its potential as a therapeutic target for conditions such as obesity, diabetes, and metabolic syndrome. The gene discussed is FFAR4; the disease is obesity due to melanocortin 4 receptor deficiency.